India Passes Three Million Cases As Experts Worry About Rapid Tests

India has become a leader in new daily COVID-19 infections, with the virus impacting poorer and older populations. While cases have reached 3 million, infections have stabilized in major cities but are rising in rural areas with weaker healthcare systems. India uses rapid antigen tests, which are cheaper and faster but less reliable, often missing early infections. Experts suggest separating antigen and molecular test data to better understand the virus spread. With a population of 1.3 billion, India ranks third globally in COVID-19 cases, following Brazil and the USA.

What has been the trend of new daily infections in India's largest cities?

How have rural areas in India been affected by the virus compared to urban areas?

What are the limitations of the rapid antigen tests used in India?

Why is it important to differentiate between antigen tests and molecular tests?

What is India's position in terms of COVID-19 caseload globally?